AXIM Biotechnologies Applauds FDA's Recent COVID-19 Test Policies to Support Rapid Neutralizing Antibody Tests SAN DIEGO, Nov. 18, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...

Thrive Launches Greybeard Cannabis Co. TORONTO, June 30, 2020 (GLOBE NEWSWIRE) -- Thrive Cannabis (“Thrive”, “Company”), a licensed producer of premium craft cannabis concentrates and dried flower, based in Simcoe, Ontario, is pleased to...